GNH USA

Europe — EMA

Aimovig

Aimovig (Erenumab) is a subcutaneous injection used for migraine prevention. Learn about its uses, effects, and precautions in this comprehensive guide.

Erenumab

Request sourcing

1
Pack/s

What is Erenumab?

Aimovig (Erenumab) is a subcutaneous injection used for migraine prevention. Learn about its uses, effects, and precautions in this comprehensive guide.

What is Erenumab used for?

Aimovig is primarily used for the prevention of migraines in adults. It is designed to reduce the frequency of migraine episodes. People often ask, 'What is Aimovig used for?' and the answer is that it is specifically indicated for migraine prevention, not for the treatment of acute migraine attacks.

What are the side effects of Erenumab?

Common effects of Aimovig may include injection site reactions, such as redness or pain. Some users might experience constipation or muscle tension. These effects vary among individuals and are not experienced by everyone.

What precautions apply to Erenumab?

Aimovig should be used with caution in individuals with a history of hypersensitivity to Erenumab or any of its components. It is important to follow the advice of a healthcare provider regarding its use and to report any unusual symptoms.

What does Erenumab interact with?

Aimovig may interact with other medications, particularly those that affect the cardiovascular system. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently asked questions

What is Aimovig used for?+
Aimovig is used for the prevention of migraines in adults.
How is Aimovig administered?+
Aimovig is administered via subcutaneous injection.
What are the common side effects of Aimovig?+
Common side effects may include injection site reactions, constipation, and muscle tension.
Can Aimovig be used for acute migraine treatment?+
No, Aimovig is specifically indicated for migraine prevention, not for the treatment of acute migraine attacks.
Who should avoid using Aimovig?+
Individuals with a history of hypersensitivity to Erenumab or any of its components should avoid using Aimovig.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Erenumab
Route
Subcutaneous Use
Manufacturer
Novartis Europharm Limited
Origin
EU

Related products